Abstract

Malus baccata (L.) Borkh. is a widely used medical plant in Asia. Since the anti-inflammatory mechanism of this plant is not fully understood, the aim of this study was to explore the anti-inflammatory function and mechanism of Malus baccata (L.) Borkh. methanol extract (Mb-ME). For in vitro experiments, nitric oxide production assay, PCR, overexpression strategy, immunoblotting, luciferase reporter assay, and immunoprecipitation were employed to explore the molecular mechanism and the target proteins of Mb-ME. For in vivo experiments, an HCl/EtOH-induced gastritis mouse model was used to confirm the anti-inflammatory function. Mb-ME showed a strong ability to inhibit the production of nitric oxide and the expression of inflammatory genes. Mb-ME decreased NF-κB luciferase activity mediated by MyD88 and TRIF. Moreover, Mb-ME blocked the activation of Src, Syk, p85, Akt, p50, p60, IKKα/β, and IκBα in LPS-induced RAW264.7 cells. Overexpression and immunoprecipitation analyses suggested Syk and Src as the target enzymes of Mb-ME. In vitro results showed that Mb-ME could alleviate gastritis and relieve the protein expression of p-Src, p-Syk, and COX-2, as well as the gene expression of COX-2 and TNF-α. In summary, this study implied that Mb-ME performs an anti-inflammatory role by suppressing Syk and Src in the NF-κB signaling pathway, both in vivo and in vitro.

Highlights

  • Inflammation is a crucial immune response that protects our bodies from diverse pathogens

  • Possessing the Toll-interleukin receptor (TIR) domain, four adaptor proteins are able to be recruited by Toll-like receptors (TLRs): MyD88, TRIF, TIRAP, and TRAM [4,5]

  • The production of nitric oxide was downregulated by Mb-ME in a dose-dependent manner in RAW264.7 cells and peritoneal macrophages (Figure 1A,B)

Read more

Summary

Introduction

Inflammation is a crucial immune response that protects our bodies from diverse pathogens. When microorganisms such as Gram-negative bacteria with lipopolysaccharide (LPS) invade a human body, an innate immune response will be initiated within a few hours. Immune cells use pattern recognition receptors (PRRs) to sense exogenous infectious ligands whose molecular structures are broadly shared by pathogens and endogenous molecules that are released from dying and damaged cells [1]. Toll-like receptors (TLRs), well-characterized members of PRRs, are a membrane-bound protein [2,3]. Possessing the Toll-interleukin receptor (TIR) domain, four adaptor proteins are able to be recruited by TLRs: MyD88, TRIF, TIRAP, and TRAM [4,5]. The interactions between adaptor proteins and TLRs trigger transforming growth factor beta-kinase 1 (TAK1), leading to the activation of IKK complex-NF-κB and mitogen-activated protein kinases [6]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call